SENP3 and hepatocellular carcinoma: As expected, the analysis of livers from DEN-CCl4-treated mice showed that SENP3 knockdown reduced tumor number and size (Fig. 8D–F), which confirms that targeting SENP3 has therapeutic potential during HCC progression.